Hot shot: the wider promise of weight-loss jabs
Economist Podcasts
00:00
GLP-1 Drugs: Beyond Weight Loss
This chapter examines the multifaceted benefits of GLP-1 receptor agonists, initially developed for diabetes treatment, in combating obesity and enhancing various health conditions. It discusses their promising applications in heart health, kidney function, Alzheimer’s disease, and even addiction, while emphasizing the need for further research to validate these findings.
Transcript
Play full episode
